NCT06244160

Brief Summary

The goal of this feasibility study is to learn about the ability to use a different form of oxygen therapy (known as high flow oxygen therapy) in patients who have a spinal cord injury in the upper back or neck. The main questions it aims to answer are:

  1. 1.Is it possible to recruit patients to the study
  2. 2.It is possible to follow the protocol in its current format
  3. 3.What is the impact on those receiving the intervention.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
2mo left

Started Apr 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress90%
Apr 2024Aug 2026

First Submitted

Initial submission to the registry

December 8, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 6, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

April 1, 2024

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2026

Last Updated

August 5, 2025

Status Verified

July 1, 2025

Enrollment Period

2.2 years

First QC Date

December 8, 2023

Last Update Submit

July 31, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Recruitment rates

    This will explore the ability to recruit eligible participants in a timely fashion as per the protocol. It will also capture the participant retainment rates during the study E.g., number of patients recruited, and % of those recruited completing study

    10 days

Secondary Outcomes (5)

  • To determine the acceptability of the intervention

    10 days

  • Physiotherapy time

    10 days

  • Frequency of physiotherapy interventions

    10 days

  • Pulmonary complications

    10 days

  • Incidence of ICU admission

    10 days

Study Arms (2)

Intervention

EXPERIMENTAL

High flow oxygen therapy delivered via nasal cannalue

Other: High flow oxygen therapy

Control

NO INTERVENTION

Standard care with oxygen therapy as required.

Interventions

High flow oxygen therapy delivered via nasal cannulae, at 50 litres flow with variable oxygen levels

Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Spinal cord injury between C4 and T4 (Include ASIA A-D)
  • Admitted to spinal injury ward within 24-48hours of injury

You may not qualify if:

  • Aged under 18 years
  • or more rib fractures or flail
  • Sternal fracture
  • Concomitant lung injury
  • Unable to gain informed consent from participant
  • Contra-indication to using high flow therapy e.g., undrained pneumothorax, facial fractures, nasal obstruction, CSF leak, suspected or confirmed base of skull fracture, active epistaxis or recent functional endoscopic sinus surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cardiff and Vale University Health Board

Cardiff, CF144XW, United Kingdom

RECRUITING

MeSH Terms

Conditions

Spinal Cord InjuriesRespiratory Insufficiency

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and InjuriesRespiration DisordersRespiratory Tract Diseases

Study Officials

  • Paul Twose

    Cardiff and Vale University Health Board

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Feasibility randomised control trial
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 8, 2023

First Posted

February 6, 2024

Study Start

April 1, 2024

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

August 1, 2026

Last Updated

August 5, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

No plan to for IPD sharing

Locations